Phreesia's Epic Alliance Deepens: A Game Changer or Integration Hurdle?
Ciena Soars to New Heights with Record Orders: Analyst Raises Forecasts on Unprecedented Visibility
A Major Setback for Amgen: Bemarituzumab's Gastric Cancer Ambitions Dim as Final Data Fails to Impress
Sanofi Stock Plunges as Zantac Lawsuit Risks Re-Emerge Following Key Judicial Ruling
Telix Pharmaceuticals Faces Second Major FDA Hurdle for Critical Kidney Cancer Diagnostic
The Global Skies Await: Are US eVTOL Pioneers Falling Behind in the Race for Future Flight?
Kyverna Therapeutics: Charting a Course for Revolutionary Autoimmune CAR T Therapy by 2026
Unlocking Value: Why Analysts See Further Divestitures on Medtronic's Horizon
Carlsmed's Personalized Spine Implants Revolutionize Care with Landmark Reimbursement Approval
Buffett's Bold Bet: Why Berkshire Hathaway Is Doubling Down on UnitedHealth